Louisiana Senate Bill SB372

Louisiana 2026 Regular Session

• Introduced: 2/27/26
• Refer: 2/27/26
• Refer: 3/9/26

Caption

Provides relative to pharmacy benefit managers. (8/1/26)

Impact

The enactment of SB 372 is expected to strengthen accountability among pharmacy benefit managers by allowing for deeper scrutiny into their operations and financial arrangements with healthcare providers and insurers. By expanding the commissioner’s oversight capabilities, the bill seeks to protect consumers and improve the transparency of drug pricing. This could lead to more informed decisions regarding the usage of PBMs and how they affect the costs of prescription medications for patients.

Summary

Senate Bill 372, proposed by Senator Bass, addresses the oversight and transparency of pharmacy benefit managers (PBMs) in Louisiana. The bill amends existing legislation to grant the commissioner of insurance additional authority to examine not only the records of PBMs but also those of any entity within the PBM's corporate vertical structure. This change aims to ensure the accuracy of annual transparency reports submitted by these entities, enhancing the regulatory framework surrounding PBMs in the state.

Sentiment

Overall, the sentiment around SB 372 appears supportive among advocates for increased transparency and accountability in healthcare practices. Stakeholders who favor the bill argue that it will benefit consumers by ensuring that PBMs are not operating with opacity in their dealings. There may be concerns from PBMs regarding the regulatory burden this increased scrutiny could impose, but the general sentiment among consumer advocates is positive.

Contention

Notable points of contention regarding SB 372 revolve around the balance of regulatory oversight and the operational freedom of pharmacy benefit managers. Some opponents may argue that while transparency is necessary, excessive regulation could stifle innovation or increase operational costs for PBMs, which might ultimately be passed on to consumers. The debate will likely focus on finding an equilibrium that maintains consumer protection while allowing PBMs the flexibility to operate efficiently.